Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
暂无分享,去创建一个
K. Hirata | A. Yagihashi | N. Sato | Y. Wada | K. Kikuchi | H. Kameshima | T. Yajima | N. Watanabe | N. Uehara | A. Matsuura | K. Sasaki
[1] H. Stein,et al. Telomerase activity in bladder cancer, bladder washings and in urine. , 1996, International journal of oncology.
[2] K. Ohyashiki,et al. Non‐radioisotopic and Semi‐quantitative Procedure for Terminal Repeat Amplification Protocol , 1996, Japanese journal of cancer research : Gann.
[3] J. Shay,et al. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. , 1995, Nucleic acids research.
[4] K. Hirata,et al. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA‐A31 molecule , 1995, Cancer.
[5] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[6] K. Hirata,et al. In vitro proliferation and the cytotoxic specificity of a cryopreserved cytotoxic T cell clone reacting against human autologous tumor cells. , 1992, Journal of immunological methods.
[7] A. Yagihashi,et al. Establishment and Characterization of New Cell Lines Derived from Human Pancreatic Cancers , 1986 .
[8] K. Hirata,et al. Establishment and Characterization of a Human Pancreatic Cancer Cell Line (HPC-1) , 1985 .